| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.000 | 110.328 | 114.916 | 105.199 | 106.373 | 87.914 | 132.973 | 125.561 | 52.816 | 0 |
| Total Income - EUR | 8.000 | 110.328 | 114.936 | 105.425 | 106.373 | 87.914 | 134.994 | 125.561 | 52.816 | 0 |
| Total Expenses - EUR | 281 | 15.543 | 18.270 | 15.549 | 16.831 | 13.698 | 14.421 | 15.443 | 8.613 | 740 |
| Gross Profit/Loss - EUR | 7.718 | 94.785 | 96.666 | 89.877 | 89.541 | 74.215 | 120.574 | 110.118 | 44.203 | -740 |
| Net Profit/Loss - EUR | 7.478 | 88.650 | 94.391 | 88.825 | 88.478 | 73.397 | 119.251 | 108.888 | 43.675 | -740 |
| Employees | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Biosano Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 9.066 | 6.627 | 4.271 | 2.004 | 1.431 | 852 | 328 | 109 |
| Current Assets | 9.864 | 94.431 | 94.724 | 107.650 | 113.068 | 97.220 | 118.930 | 110.503 | 43.396 | 8.455 |
| Inventories | 0 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 8.000 | 12.747 | 13.536 | 15.205 | 15.098 | 13.645 | 16.977 | 83.065 | 34.431 | 63 |
| Cash | 1.865 | 81.684 | 81.188 | 92.436 | 97.970 | 83.576 | 101.953 | 27.437 | 8.965 | 8.392 |
| Shareholders Funds | 7.523 | 88.704 | 94.444 | 111.588 | 115.891 | 97.813 | 119.299 | 108.936 | 43.724 | 8.564 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.422 | 5.812 | 9.564 | 2.706 | 1.810 | 1.591 | 1.187 | 2.540 | 0 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Biosano Medica Srl